An experimental and theoretical investigation of deposition patterns from an agricultural airplane

A flight test program has been conducted with a representative agricultural airplane to provide data for validating a computer program model which predicts aerially applied particle deposition. Test procedures and the data from this test are presented and discussed. The computer program features are summarized, and comparisons of predicted and measured particle deposition are presented. Applications of the computer program for spray pattern improvement are illustrated

Study of the Mutual Interaction Between a Wing Wake and an Encountering Airplane

In an effort to increase airport productivity, several wind-tunnel and flight-test programs are currently underway to determine safe reductions in separation standards between aircraft. These programs are designed to study numerous concepts from the characteristics and detection of wake vortices to the wake-vortex encounter phenomenon. As part of this latter effort, computational tools are being developed and utilized as a means of modeling and verifying wake-vortex hazard encounters. The objective of this study is to assess the ability of PMARC, a low-order potential-flow panel method, to predict the forces and moments imposed on a following business-jet configuration by a vortex interaction. Other issues addressed include the investigation of several wake models and their ability to predict wake shape and trajectory, the validity of the velocity field imposed on the following configuration, modeling techniques and the effect of the high-lift system and the empennage. Comparisons with wind-tunnel data reveal that PMARC predicts the characteristics for the clean wing-body following configuration fairly well. Non-linear effects produced by the addition of the high-lift system and empennage, however, are not so well predicted

Numerical simulation of helicopter engine plume in forward flight

Flowfields around helicopters contain complex flow features such as large separated flow regions, vortices, shear layers, blown and suction surfaces and an inherently unsteady flow imposed by the rotor system. Another complicated feature of helicopters is their infrared signature. Typically, the aircraft's exhaust plume interacts with the rotor downwash, the fuselage's complicated flowfield, and the fuselage itself giving each aircraft a unique IR signature at given flight conditions. The goal of this project was to compute the flow about a realistic helicopter fuselage including the interaction of the engine air intakes and exhaust plume. The computations solve the Think-Layer Navier Stokes equations using overset type grids and in particular use the OVERFLOW code by Buning of NASA Ames. During this three month effort, an existing grid system of the Comanche Helicopter was to be modified to include the engine inlet and the hot engine exhaust. The engine exhaust was to be modeled as hot air exhaust. However, considerable changes in the fuselage geometry required a complete regriding of the surface and volume grids. The engine plume computations have been delayed to future efforts. The results of the current work consists of a complete regeneration of the surface and volume grids of the most recent Comanche fuselage along with a flowfield computation

Flight evaluation of the effect of winglets on performance and handling qualities of a single-engine general aviation airplane

A flight evaluation was conducted to determine the effects of winglets on the performance and handling qualities of a light, single-engine general aviation airplane. The performance measurements were made with a pace airplane to provide calibrated airspeeds; uncalibrated panel instruments in the test airplane were used to provide additional quantitative performance data. These tests were conducted with winglets on and off during the same day to measure relative performance effects. Handling qualities were evaluated by means of pilot comments. Winglets increased cruise speed 8 knots (5.6 percent) at 3962 m (13,000 ft) density altitude and 51 percent maximum continuous power setting. Maximum speed at 3962 m was virtually unchanged. Rate of climb increased approximately 6 percent, or 0.25 m/sec (50 ft/min), at 1524 m (5000 ft). Stall speed was virtually unchanged. Handling qualities were favorably affected

Parental origin of sequence variants associated with complex diseases

To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldEffects of susceptibility variants may depend on from which parent they are inherited. Although many associations between sequence variants and human traits have been discovered through genome-wide associations, the impact of parental origin has largely been ignored. Here we show that for 38,167 Icelanders genotyped using single nucleotide polymorphism (SNP) chips, the parental origin of most alleles can be determined. For this we used a combination of genealogy and long-range phasing. We then focused on SNPs that associate with diseases and are within 500 kilobases of known imprinted genes. Seven independent SNP associations were examined. Five-one with breast cancer, one with basal-cell carcinoma and three with type 2 diabetes-have parental-origin-specific associations. These variants are located in two genomic regions, 11p15 and 7q32, each harbouring a cluster of imprinted genes. Furthermore, we observed a novel association between the SNP rs2334499 at 11p15 and type 2 diabetes. Here the allele that confers risk when paternally inherited is protective when maternally transmitted. We identified a differentially methylated CTCF-binding site at 11p15 and demonstrated correlation of rs2334499 with decreased methylation of that site.info:eu-repo/grantAgreement/EC/FP7/21807

Effects of NK-4 in a Transgenic Mouse Model of Alzheimer's Disease

Beta-amyloid (Aβ) peptides are considered to play a major role in the pathogenesis of Alzheimer's disease (AD) and molecules that can prevent pathways of Aβ toxicity may be potential therapeutic agents for treatment of AD. We have previously reported that NK-4, a cyanine photosensitizing dye, displays neurotrophic and antioxidant activities. In this study, we report the effects of NK-4 on the toxicity of Aβ and on cognitive function and Aβ concentration in a transgenic mouse model of AD (Tg2576). In vitro, NK-4 effectively protected neuronal cells from toxicity induced by Aβ. In addition, it displayed profound inhibitory activities on Aβ fibril formation. In vivo, Tg2576 mice received an intraperitoneal injection at 100 or 500 µg/kg of NK-4 once a day, five times a week for 9 months. Administration of NK-4 to the mice attenuated impairment of recognition memory, associative memory, and learning ability, as assessed by a novel object recognition test, a passive avoidance test, and a water maze test, respectively. NK-4 decreased the brain Aβ concentration while increasing the plasma amyloid level in a dose-dependent manner. NK-4 also improved memory impairments of ICR mice induced by direct intracerebroventricular administration of Aβ. These lines of evidence suggest that NK-4 may affect multiple pathways of amyloid pathogenesis and could be useful for treatment of AD

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.